Martin David Harp

Bausch + Lomb and Modulight announce the photodynamic laser for use with photodynamic therapy was approved by the FDA for the treatment of patients with subfoveal choroidal neovascularization due to AMD.

HG004 aims to be more effective than other AAV2 products in treatment of inherited retinal diseases caused by mutations in the RPE65 gene.

Vial will be supporting RecensMedical with the phase 3 clinical trial for its Ocu-Cool system.

The Phase 2 clinical trial will evaluate darovasertib as monotherapy in neo-adjuvant and adjuvant settings in primary, non-metastatic uveal melanoma (UM) patients.

The intent of the award is to recognize early-career researchers who have exhibited excellence in research, as well as their fundamental scientific discoveries, concepts and novel technologies which have led to, or have the promise of leading to, clinical application.

After comparing two techniques of corneal transplant tissue preparation, research shows a newer, faster technique is safe and effective.

These awards will help to advance the winner’s work and research in their respective fields in retinal surgery and age-related macular degeneration (AMD).

The Genentech Award is intended to provide early-career underrepresented minority investigators with an opportunity to explore novel and innovative research project ideas.

Topical formulation of TTHX1114 has potential to accelerate the healing of epithelial defects

The ARVO Foundation Collaborative Research Fellowship is intended to promote international scientific interactions and innovative research.